Sodium Intake in Ecuadorian Population
Sodium Urinary Excretion Measurement in Ecuadorian Population
1 other identifier
observational
130
0 countries
N/A
Brief Summary
This study is aim to determine the sodium intake in Ecuadorian population that is an unknown information at present. For that, 24h urine samples will be collected from 130 subjects working either at tue USFQ or HDLV to measure sodium excretion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2016
CompletedFirst Submitted
Initial submission to the registry
May 12, 2017
CompletedFirst Posted
Study publicly available on registry
May 16, 2017
CompletedMay 16, 2017
May 1, 2017
1.7 years
May 12, 2017
May 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Urinary sodium excretion
Amount of sodium in 24h urine collection
1 year
Interventions
Urinary sodium and potassium were measured using the Ion-Selective Electrode (ISE) indirect Na-K-Cl for Gen.2 (Roche Diagnostic, Switzerland).
Eligibility Criteria
Will be enrolled a sample of 178 adults aged 25 to 64 years. The research team, who have faculty appointments in USFQ, supervised the collection of the urine samples. We invited a broad spectrum of employees (which included health care workers, professors, and custodial staff) from both institutions to participate in the study.
You may qualify if:
- None
You may not qualify if:
- unable to provide informed consent
- unable to provide 24-hr urine excretion sample
- those with a known history of heart or kidney failure, stroke, and liver disease
- those using diuretics, multivitamins, NSADs, or prostaglandins during the last two weeks
- pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Enrique Teran, MD, PhD
Universidad San Francisco de Quito
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 12, 2017
First Posted
May 16, 2017
Study Start
March 1, 2015
Primary Completion
October 30, 2016
Study Completion
October 30, 2016
Last Updated
May 16, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share